by admin | Jul 26, 2022 | News & Opinions
By Max Bayer – Fierce Biotech Just a week after Vertex’s stem cell therapy to treat type 1 diabetes was released from an FDA clinical hold, the company is clearing out potential competition by buying ViaCyte for $320 million. The all-cash deal announced Monday...
by admin | Jun 9, 2022 | News & Opinions, Video, Video Chats
On June 9 at 7:00 PM EDT, Regenerative Medicine Foundation (RMF) broadcast the Stem Cell and Regenerative Medicine Action Awards as part of the combined virtual 17th annual World Stem Cell Summit (WSCS) and Wake Forest Institute for Regenerative Medicine and RMF’s...
by admin | Jun 2, 2022 | News & Opinions
Boerne, TX. June 1, 2022 — Cell Bridge Strategies, an industry thought leader and consulting firm for Regenerative Medicine and the Advanced Therapies announced its sponsorship and design of an executive-level panel session to address the significant impact India is...
by admin | Jan 20, 2022 | News & Opinions
NIAID Scientists Developed Vaccine Platform Image Caption: Scanning electromicrograph of an HIV-infected H9 T cell. Credit: NIAID December 9, 2021 – (Link to article) – An experimental HIV vaccine based on mRNA—the same platform technology used in two...
by admin | Aug 4, 2020 | News & Opinions, Video, Video Chats
Bernie’s Interview with Dana Cairns & David Kaplan of Tufts University 0:00 Intro 1:30 Alzheimers Research Findings Review – Dana Cairns 4:01 Using biomaterials; not “mini-brains” but caterpillar silk 4:30 David Kaplan 7:45 IPSC &...
